Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $70.19 | $30.36 | 131.16% | 55.71x | 58.13x | 10.21x | 11.63x | 1.09x | $180.28M | 2.47% | $635.79M | 6.11 | $7.30B | 71.45 | ||
| TGTX | TG THERAPEUTICS INC | $27.92 | $13.88 | 101.12% | 68.10x | 36.34x | 9.02x | 16.03x | 0.87x | -$59.24M | -1.45% | $276.43M | 1.88 | $4.55B | 46.68 | ||
| CRMD | CORMEDIX INC | $13.06 | $12.32 | 6.03% | 50.23x | 10.73x | 10.32x | 7.71x | 0.44x | -$13.63M | -1.60% | $114.89M | 1.76 | $819.98M | 46.41 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.53 | $3.88 | 94.23% | 188.25x | 17.93x | 6.56x | 7.88x | 0.75x | $73.00k | 0.01% | $92.03M | 1.03 | $690.14M | 70.00 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $33.15 | $5.31 | 524.85% | 552.50x | 32.18x | 4.60x | 4.96x | 2.41x | $66.49M | 2.73% | $495.01M | 6.74 | $2.27B | 119.43 | ||
| KRYS | KRYSTAL BIOTECH INC | $143.96 | $89.67 | 60.55% | 28.17x | 30.06x | 11.59x | 4.00x | 0.86x | $185.88M | 4.47% | $1.04B | 36.00 | $3.82B | 21.84 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.98 | $57.78 | 21.11% | 15.62x | 11.88x | 7.20x | 24.60x | 0.78x | $540.69M | 6.37% | $332.75M | 2.74 | $9.63B | 12.16 | ||
| EXEL | EXELIXIS INC | $37.52 | $28.82 | 30.19% | 17.45x | 16.13x | 4.59x | 4.97x | 0.81x | $754.07M | 7.37% | $2.03B | 7.46 | $10.12B | 12.17 | ||
| RPRX | ROYALTY PHARMA PLC | $36.00 | $49.52 | -27.31% | 15.58x | 7.89x | 6.61x | 2.21x | 0.36x | $2.11B | 13.86% | $9.50B | 22.44 | $28.36B | 22.04 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $12.03 | $6.99 | 72.11% | 27.34x | 18.68x | 6.24x | 4.72x | 0.97x | $92.38M | 5.69% | $335.30M | 2.49 | $1.61B | 18.64 | ||
| INVA | INNOVIVA INC | $20.52 | $16.73 | 22.63% | 33.64x | 10.36x | 3.48x | 1.81x | 0.56x | $196.35M | 15.22% | $714.82M | 11.37 | $1.34B | 10.72 | ||
| VCEL | VERICEL CORP | $36.17 | $5.16 | 601.51% | 258.36x | 183.88x | 7.31x | 5.95x | 3.00x | -$8.30M | -0.46% | $306.81M | 6.09 | $1.84B | 83.60 | ||
| ARGX | ARGENX SE | $656.89 | $210.32 | 212.33% | 26.25x | 40.95x | 21,190.00x | 5.59x | 3.46x | $467.72M | 1.17% | $7.17B | 117.50 | $37.69B | 46.46 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.40 | $35.39 | 2.87% | 11.52x | 11.54x | 2.71x | 2.71x | 0.75x | $258.73M | 12.37% | $773.08M | 13.45 | $1.72B | 6.49 | ||
| INCY | INCYTE CORP | $85.46 | $59.73 | 43.08% | 19.33x | 16.88x | 3.62x | 4.00x | 0.89x | $958.08M | 5.78% | $4.17B | 21.50 | $14.77B | 10.90 | ||
| ADMA | ADMA BIOLOGICS INC | $17.44 | $9.31 | 87.35% | 19.82x | 27.68x | 8.88x | 10.45x | 1.46x | $65.77M | 1.56% | $398.33M | 1.65 | $4.15B | 25.42 | ||
| MNKD | MANNKIND CORP | $3.96 | $1.50 | 164.08% | 36.00x | 45.26x | 4.00x | -22.07x | 1.63x | $28.79M | 2.37% | -$55.04M | -0.18 | $1.45B | 18.27 | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $11.48 | $19.05 | -39.73% | 15.73x | -3.28x | 0.74x | -2.30x | 0.28x | -$63.66M | -45.46% | -$35.04M | -2.87 | $119.37M | 4.80 | ||
| MDXG | MIMEDX GROUP INC | $7.19 | $4.64 | 55.09% | 32.68x | 25.23x | 2.92x | 4.91x | 0.77x | $57.13M | 5.38% | $216.62M | 1.47 | $963.42M | 17.72 | ||
| TECH | BIO-TECHNE CORP | $54.87 | $19.63 | 179.46% | 66.11x | 31.13x | 7.14x | 4.26x | 1.33x | $220.76M | 2.56% | $2.02B | 12.82 | $8.88B | 30.68 | ||
| VCYT | VERACYTE INC | $29.57 | $9.35 | 216.14% | 68.77x | 34.28x | 4.98x | 1.94x | 1.54x | $78.45M | 3.40% | $1.19B | 15.31 | $2.18B | 34.56 | ||
| NVO | NOVO NORDISK A S | $54.78 | $29.94 | 82.97% | 14.06x | 14.08x | 5.03x | 9.33x | 2.51x | $10.18B | 4.16% | $26.22B | 5.87 | $257.20B | 10.52 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.31 | $41.72 | 37.38% | 16.66x | 15.48x | 3.59x | 1.83x | 0.93x | $694.91M | 6.32% | $6.03B | 31.41 | $10.39B | 11.12 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $9.63 | $1.31 | 634.27% | 41.87x | 76.01x | 6.56x | 11.96x | 409.35x | $20.95M | 2.74% | $64.20M | 0.81 | $710.84M | 35.94 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $20.25 | $18.63 | 8.71% | 11.71x | 9.33x | 4.43x | 2.90x | 0.83x | $274.72M | 11.11% | $856.03M | 7.01 | $1.83B | 5.90 | ||
| GMAB | GENMAB A | $23.82 | $17.36 | 37.21% | 12.09x | 14.45x | 4.61x | 2.88x | 1.39x | $938.44M | 6.14% | $5.30B | 8.26 | $14.12B | 7.77 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $390.76 | $131.88 | 196.31% | 27.67x | 24.59x | 8.78x | 5.83x | 2.72x | $3.50B | 3.49% | $17.18B | 66.91 | $96.74B | 21.07 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.